189 related articles for article (PubMed ID: 11724658)
1. Quantification of vascular endothelial growth factor-A in leiomyomas and adjacent myometrium.
Gentry CC; Okolo SO; Fong LF; Crow JC; Maclean AB; Perrett CW
Clin Sci (Lond); 2001 Dec; 101(6):691-5. PubMed ID: 11724658
[TBL] [Abstract][Full Text] [Related]
2. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density.
Hague S; Zhang L; Oehler MK; Manek S; MacKenzie IZ; Bicknell R; Rees MC
Clin Cancer Res; 2000 Jul; 6(7):2808-14. PubMed ID: 10914728
[TBL] [Abstract][Full Text] [Related]
3. Different expression of estrogen receptors alpha and beta in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment.
Wang H; Wu X; Englund K; Masironi B; Eriksson H; Sahlin L
Gynecol Endocrinol; 2001 Dec; 15(6):443-52. PubMed ID: 11826769
[TBL] [Abstract][Full Text] [Related]
4. The expression of Abl interactor 2 in leiomyoma and myometrium and regulation by GnRH analogue and transforming growth factor-beta.
Luo X; Levens E; Williams RS; Chegini N
Hum Reprod; 2006 Jun; 21(6):1380-6. PubMed ID: 16488906
[TBL] [Abstract][Full Text] [Related]
5. Expression of basic fibroblast growth factor (bFGF), FGF receptor 1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle, after menopause and GnRHa treatment.
Wu X; Blanck A; Olovsson M; Möller B; Lindblom B
Acta Obstet Gynecol Scand; 2001 Jun; 80(6):497-504. PubMed ID: 11380284
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen activator inhibitor 1 messenger RNA expression and molecular evidence for del(7)(q22) in uterine leiomyomas.
Sourla A; Polychronakos C; Zeng WR; Nepveu A; Kukuvitis A; Naud F; Koutsilieris M
Cancer Res; 1996 Jul; 56(13):3123-8. PubMed ID: 8674071
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of von Willebrand factor, CD34, CD31, and vascular endothelial growth factor expression in women with uterine leiomyosarcomas.
Poncelet C; Fauvet R; Feldmann G; Walker F; Madelenat P; Darai E
J Surg Oncol; 2004 May; 86(2):84-90. PubMed ID: 15112250
[TBL] [Abstract][Full Text] [Related]
8. Clinical response, vascular change, and angiogenesis in gonadotropin-releasing hormone analogue-treated women with uterine myomas.
Di Lieto A; De Falco M; Pollio F; Mansueto G; Salvatore G; Somma P; Ciociola F; De Rosa G; Staibano S
J Soc Gynecol Investig; 2005 Feb; 12(2):123-8. PubMed ID: 15695108
[TBL] [Abstract][Full Text] [Related]
9. Expression of the O-linked N-acetylglucosamine containing epitope H in normal myometrium and uterine smooth muscle cell tumors.
Sgantzos MN; Galani V; Arvanitis LD; Charchanti A; Psathas P; Nakou M; Havaki S; Kallioras V; Marinos E; Vamvakopoulos NC; Kittas C
Pathol Res Pract; 2007; 203(1):31-7. PubMed ID: 17129677
[TBL] [Abstract][Full Text] [Related]
10. Expression of vascular endothelial growth factor mRNA in human leiomyomas.
Lewicka A; Osuch B; Cendrowski K; Zegarska J; Stelmachów J
Gynecol Endocrinol; 2010 Jun; 26(6):451-5. PubMed ID: 20443739
[TBL] [Abstract][Full Text] [Related]
11. Preoperative administration of GnRH-a plus tibolone to premenopausal women with uterine fibroids: evaluation of the clinical response, the immunohistochemical expression of PDGF, bFGF and VEGF and the vascular pattern.
Di Lieto A; De Falco M; Mansueto G; De Rosa G; Pollio F; Staibano S
Steroids; 2005 Feb; 70(2):95-102. PubMed ID: 15631865
[TBL] [Abstract][Full Text] [Related]
12. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of gonadotropin-releasing hormone analogue treatment on estrogen levels and sulfatase activity in uterine leiomyoma and myometrium.
van de Ven J; Donker TH; Blankenstein MA; Thijssen JH
Fertil Steril; 2002 Jun; 77(6):1227-32. PubMed ID: 12057733
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial factor-A, gelatinases (MMP-2, MMP-9) and TIMP-1 in uterine leiomyomas.
Korompelis P; Piperi C; Adamopoulos C; Dalagiorgou G; Korkolopoulou P; Sepsa A; Antsaklis A; Papavassiliou AG
Clin Chem Lab Med; 2015 Aug; 53(9):1415-24. PubMed ID: 25470608
[TBL] [Abstract][Full Text] [Related]
15. An accumulation of insulin-like growth factor I (IGF-I) in human myometrium and uterine leiomyomas in various stages of tumour growth.
Wolańska M; Bańkowski E
Eur Cytokine Netw; 2004; 15(4):359-63. PubMed ID: 15627646
[TBL] [Abstract][Full Text] [Related]
16. [Study on the expression of vascular endothelial growth factor in patients with adenomyosis of the uterus].
Han Y; Zhou Y; Zheng S
Zhonghua Fu Chan Ke Za Zhi; 2002 Sep; 37(9):539-41. PubMed ID: 12411015
[TBL] [Abstract][Full Text] [Related]
17. Fibromodulin is expressed in leiomyoma and myometrium and regulated by gonadotropin-releasing hormone analogue therapy and TGF-beta through Smad and MAPK-mediated signalling.
Levens E; Luo X; Ding L; Williams RS; Chegini N
Mol Hum Reprod; 2005 Jul; 11(7):489-94. PubMed ID: 16123076
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women.
Baytur YB; Ozbilgin K; Cilaker S; Lacin S; Kurtul O; Oruc S; Koyuncu FM
Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):94-103. PubMed ID: 16973256
[TBL] [Abstract][Full Text] [Related]
19. [Expression of bcl-2 protein in uterine leiomyomas and normal myometrium].
Zhang ZL; Zhang Y; Xu BQ
Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):363-5. PubMed ID: 12536738
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta and platelet-derived growth factor in human myometrium and in uterine leiomyomas at various stages of tumour growth.
Wolańska M; Bańkowski E
Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):238-44. PubMed ID: 16564125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]